Meetings of Interest

OTS' Next Annual Meeting:

October 28-31, 2012   Boston, Masachusetts

Join leading experts in the field during this three day meeting, which will feature the latest developments from various oligonucleotide-based disciplines including antisense, siRNA, immunomodulatory, aptamers and micro/non-coding RNA research. 

Registration will open by mid-March and more details posted soon.  Please check back with us!


 

Other Meetings and Conferences:

April 16-April 18
DIA/FDA Oligonucleotide-based Therapeutics 2012: Leveraging Regulatory and Industry Knowledge for Future Advancements
Washington DC, USA

Join Industry and Global Regulatory Representatives to Discuss Advances in Oligonucleotide Science

For the past four years DIA/FDA has convened industry and health authorities to inform, educate, and share advancements in oligonucleotide-based therapeutic product development. The 2012 event will continue to address bioinformatics, microRNAs, delivery methods, impurity issues, metabolism, non-clinical assessments in support of drug development and clinical advances in therapeutic targets, trial design and safety. This conference will also incorporate dialogue to address RNA interference technologies and expand clinical pharmacology representation in discussions of the emerging technologies being developed in the field of oligonucleotide-based therapeutics.

FEATURED TOPICS:
• Non-Clinical
• Chemistry, Manufacturing, and Controls (CMC)
• Clinical Development
• Oligonucleotide Safety Working Group Updates


May 20-23, 2012
TIDES
Las Vegas, NV, USA

Oligonucleotide and Peptide Research, Technology and Product Development

 

May 29 - June 3, 2012
RNA Society Annual Meeting
Ann Arbor, MI, USA

Organizers:

          Rachel Green
          Nils Walter
          Melissa Moore
          Gerhart Wagner

Highlights of the Meeting:

  • Opening night with three plenary speakers: Brenda Bass (Utah), Olke Uhlenbeck (Northwestern) and Jonathan Weissman (UCSF)
  • 12 diverse sessions on Small RNAs, Non-coding RNAs, Translation, Pre-mRNA splicing, Catalytic RNAs, mRNA turnover, Regulation of gene expression, RNA Structure/Function, Disease/Pathogen/Therapeutics, Structure and function of RNA-protein complexes, and Bioinformatics/systems biology
  • Each session with an introductory plenary lecture, an overview talk by the session chair, and a rapid fire of short talks chosen from the submitted abstracts.
  • 4 workshops on hot topics solicited from suggestions and abstracts
  • Beer Hall
  • Junior Scientists Social
  • Mentor-Mentee Lunch
  • Career Development Workshop
  • Awards ceremony with poster and talk prizes
  • RNA & Society Dinner featuring Laurie Zoloth, a well-known bioethicist
  • Banquet & Dance at the Henry Ford science and technology museum with a special Titanic exhibition and dancing under a vintage airplane

August 5-9, 2012
XX International Roundtable of Nucleosides, Nucleotides and Nucleic Acids
Montreal, Quebec, Canada

Organizers:

            Masad J. Damha, McGill University

            Robert H.E. Hudson, University of Western Ontario

            Christopher J. Wilds, Concordia University

The conference commences with an evening reception on August 5th on the McGill University Campus, and concludes with a memorable evening banquet in the heart of downtown Montreal. In between those festivities, we will have a strong and varied program of plenary sessions and contributed lectures. As in past International Roundtables (IRTs), poster presentations will form an important part of the scientific program; posters will be displayed all week and featured in two early evening sessions. We are delighted to be hosting the IRT for the first time in our beautiful city, almost 40 years after the initial IRT conference, held in Montpellier, France in 1974. Plenary lectures will be given by internationally recognized scientists, including the Montgomery and Imbach-Townsend Awardees. We will have a dynamic and engaging program with varied cutting edge research in medicinal chemistry, biochemistry, and molecular biology, as well as synthetic and therapeutic applications of nucleosides and oligonucleotides. We are confident that the IRT will be a stimulating and exciting meeting in the tradition of past IRT conferences. You will find the IRT to be conducive to scientific exchange and the city of Montreal to be an enjoyable, vibrant and stimulating location. Your participation in the conference is essential to the success of the event. The new IS3NA website will have all the information about the IRT, including registration and submission of abstracts.

 

October 7-11, 2012
ECI Conference on Oligonucleotide Delivery: Biology, Engineering and Development
Seminar Hotel: Schloss Hernstein, Austria
Organizers:

Laura Sepp-Lorenzino, Merck & Co., Inc.
Steven F. Dowdy, Howard Hughes Medical Institute, UCSD School of Medicine
Michael Gait, MRC Laboratory of Molecular Biology
Gilles Divita, CNRS

 

October 28-31, 2012
8th Annual Meeting of the Oligonucleotide Therapeutics Society
The Joseph B. Martin Conference Center at Harvard Medical School, Cambridge, MA, USA